Reduction-Sensitive Polymer-Shell-Coated Nanogels for Intracellular Delivery of Antigens
Source abstract
Abstract
Nowadays, layer-by-layer assembled microsized particles receive interest as drug delivery systems. In the present study, we report nanosized hydrogels loaded with a protein antigen that are coated with a disulfide cross-linked polymer shell. These disulfide bonds are stable in the nonreducing extracellular environment, but are reduced in the intracellular environment. This in turn leads to disintegration of the polymer shell and subsequent antigen release. Furthermore, we demonstrate the ability of these core–shell nanogels to boost the MHC class I antigen presentation by dendritic cells to CD8 + T cells.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Immunotherapy and Immune Responses · RNA Interference and Gene Delivery · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3584 CG Utrecht, The Netherlands
Funding
China Scholarship Council
References (40)
Show source-provided references
1. 10.1016/j.addr.2011.03.01610.1016/j.addr.2011.03.016 ↗
2. 10.1002/anie.20090626610.1002/anie.200906266 ↗
3. 10.1021/nn700408z10.1021/nn700408z ↗
4. 10.1021/ja807059k10.1021/ja807059k ↗
5. 10.1021/am505681e10.1021/am505681e ↗
6. 10.2147/IJN.S3814410.2147/IJN.S38144 ↗
7. 10.1021/ab500050m10.1021/ab500050m ↗
8. 10.1016/S1369-7021(12)70090-110.1016/S1369-7021(12)70090-1 ↗
9. 10.1155/2015/53509210.1155/2015/535092 ↗
10. 10.1021/acsbiomaterials.5b0037510.1021/acsbiomaterials.5b00375 ↗
11. 10.1002/anie.20120004810.1002/anie.201200048 ↗
12. 10.1021/nn205099c10.1021/nn205099c ↗
13. 10.1021/cm702481310.1021/cm7024813 ↗
14. 10.1021/nn502861t10.1021/nn502861t ↗
15. 10.1021/la047648010.1021/la0476480 ↗
16. 10.1073/pnas.060288410310.1073/pnas.0602884103 ↗
17. 10.1021/nn204319b10.1021/nn204319b ↗
18. 10.1002/adhm.20160029210.1002/adhm.201600292 ↗
19. 10.1016/j.actbio.2015.07.02410.1016/j.actbio.2015.07.024 ↗
20. 10.1002/anie.20160218810.1002/anie.201602188 ↗
21. 10.1016/j.jconrel.2014.06.01210.1016/j.jconrel.2014.06.012 ↗
22. 10.1002/anie.20150862610.1002/anie.201508626 ↗
23. 10.1016/j.jconrel.2011.01.03010.1016/j.jconrel.2011.01.030 ↗
24. 10.1021/acsbiomaterials.5b0020310.1021/acsbiomaterials.5b00203 ↗
25. 10.1021/nn103044z10.1021/nn103044z ↗
26. 10.1021/nn900715g10.1021/nn900715g ↗
27. 10.1021/acsbiomaterials.6b0001510.1021/acsbiomaterials.6b00015 ↗
28. 10.1088/0957-4484/17/23/00310.1088/0957-4484/17/23/003 ↗
29. 10.1038/nrclinonc.2013.20810.1038/nrclinonc.2013.208 ↗
30. 10.1038/nri325410.1038/nri3254 ↗
31. Cohn M. · J. Immunol. · 1949 · 61 · 28310.4049/jimmunol.61.4.283 ↗
32. 10.1021/acsnano.5b0104210.1021/acsnano.5b01042 ↗
33. 10.1016/j.biomaterials.2014.10.05310.1016/j.biomaterials.2014.10.053 ↗
34. 10.1016/j.jconrel.2015.02.00610.1016/j.jconrel.2015.02.006 ↗
35. 10.1002/adfm.20150089410.1002/adfm.201500894 ↗
36. 10.1002/adfm.20060019810.1002/adfm.200600198 ↗
37. 10.1016/j.jconrel.2008.03.01210.1016/j.jconrel.2008.03.012 ↗
38. Collins D. S. · J. Immunol. · 1991 · 147 · 405410.4049/jimmunol.147.12.4054 ↗
39. 10.1021/acsbiomaterials.5b0045610.1021/acsbiomaterials.5b00456 ↗
40. 10.2147/IJN.S3611110.2147/IJN.S36111 ↗